Super MRI scans peek inside brains of testicular cancer survivors
NCT ID NCT06191575
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study uses a very powerful 7 Tesla MRI scanner to take detailed pictures of the brain in testicular cancer patients who have low testosterone (hypogonadism) and are on testosterone replacement therapy. The goal is to see if the MRI can detect changes in brain structure and function that might be linked to symptoms like fatigue, depression, or trouble concentrating. About 10 adult men who have had testicular cancer surgery and been on testosterone therapy for at least 6 months will participate. This is an observational study only—it does not test any new treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPOGONADISM are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Los Angeles General Medical Center
Los Angeles, California, 90033, United States
-
USC / Norris Comprehensive Cancer Center
Los Angeles, California, 90033, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Testosterone may rebuild strength after spinal cord injury — trial puts it to the test
- Fertility study asks: are men still overlooked in IVF clinics?
- Can a cheap breast cancer drug fix hormone recovery in prostate cancer patients?
- Could a testosterone shot before surgery speed recovery?
- Testosterone Therapy's heart risk under the microscope
- Could pollution and sleep habits be messing with your hormones? new study investigates.